Michael Nally
About Michael Nally
Michael Nally is the CEO of Generate Biomedicines, known for his leadership in protein therapeutics and successful fundraising, raising over $750 million through Series B and C financing rounds.
Michael Nally Chief Executive Officer
Michael Nally is the Chief Executive Officer of Generate Biomedicines. With a focus on making protein therapeutics programmable, he has been at the forefront of the company’s strategic initiatives and growth. He played a crucial role in driving the company’s innovation in biomedicine and establishing key industry relationships.
Michael Nally Education and Expertise
Michael Nally holds an MBA from Harvard Business School, a degree in Accounting and Finance from the London School of Economics, and a BA in Economics from Middlebury College. His educational background equips him with a deep understanding of both the financial and operational aspects of business management, which he leverages to lead in the biomedicine sector.
Michael Nally Background
Before his tenure at Generate Biomedicines, Michael Nally held several key leadership roles at Merck & Co., Inc., including Chief Marketing Officer and President of Global Vaccines. His experience at Merck underscores his expertise in global marketing and vaccine development. In his current role, Nally has successfully completed Series B and C financing rounds, raising over $750 million for Generate Biomedicines.
Michael Nally Achievements
Michael Nally has been instrumental in forging significant partnerships for Generate Biomedicines, including a collaboration with Amgen focused on developing protein therapies. In 2023, he announced strategic collaborations with the MD Anderson Cancer Center and Roswell Park Comprehensive Cancer Center. Additionally, he serves as a board member for Flagship's Harbinger Health and PPG Industries, demonstrating his leadership and influence in the broader field of health care and industry sustainability.
Michael Nally Board Memberships and Committees
Michael Nally serves on the board for Harbinger Health and PPG Industries. At PPG Industries, he is an active member of the Audit and Sustainability and Innovation Committees. His board memberships and committee roles highlight his commitment to corporate governance and sustainable innovation in the healthcare and industrial sectors.